Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103788 · ClinicalTrials.gov registry record · NA
Evaluation of Increased Absorption of a Curcumin Emulsion (CurQ+) in Healthy Volunteers
A NA study, sponsored by ESM Technologies.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04103788: Completed NA study, sponsored by ESM Technologies.
NCT04103788 is a NA study that has completed, run by ESM Technologies. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04103788, a NA study, has completed, sponsored by ESM Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is intended to evaluate the comparative effects of direct analysis of serum samples versus pre-treatment with enzymatic hydrolysis in split samples obtained from dosing with a highly absorbed curcumin emulsion product that is commercially available as BIOCURC.
Primary Outcome
direct analysis versus enzymatic hydrolysis pre-treatment of serum samples to determine Area Under the Curve (AUC) levels in ng-hr/mL of curcumin glucuronide, curcumin sulfate, and free curcumin
Interventions
- DIETARY_SUPPLEMENT 95% Curcuminoid Powder
- DIETARY_SUPPLEMENT CurQ+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-27 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
What the finished NCT04103788 record still lists
NCT04103788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which 95% Curcuminoid Powder is the first listed.
NCT04103788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04103788 about?
NCT04103788 is a clinical study titled "Evaluation of Increased Absorption of a Curcumin Emulsion (CurQ+) in Healthy Volunteers". This study is intended to evaluate the comparative effects of direct analysis of serum samples versus pre-treatment with enzymatic hydrolysis in split samples obtained from dosing with a highly absorbed curcumin emulsion product that is commercially available as BIOCURC.
What is the current status of trial NCT04103788?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-03-27. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT04103788?
The interventions under investigation include: 95% Curcuminoid Powder (DIETARY_SUPPLEMENT), CurQ+ (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04103788?
This trial is sponsored by ESM Technologies, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04103788's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI